Product NDC: | 21695-569 |
Proprietary Name: | Chlorzoxazone |
Non Proprietary Name: | Chlorzoxazone |
Active Ingredient(s): | 500 mg/1 & nbsp; Chlorzoxazone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-569 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089895 |
Marketing Category: | ANDA |
Start Marketing Date: | 19880504 |
Package NDC: | 21695-569-30 |
Package Description: | 30 TABLET in 1 BOTTLE (21695-569-30) |
NDC Code | 21695-569-30 |
Proprietary Name | Chlorzoxazone |
Package Description | 30 TABLET in 1 BOTTLE (21695-569-30) |
Product NDC | 21695-569 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlorzoxazone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19880504 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | CHLORZOXAZONE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |